<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32457070</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>26</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.</ArticleTitle><Pagination><StartPage>5137</StartPage><EndPage>5154</EndPage><MedlinePgn>5137-5154</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1523/JNEUROSCI.0536-20.2020</ELocationID><Abstract><AbstractText>To investigate the role of neuronal NF-&#x3ba;B activity in pathogenesis of amyotrophic lateral sclerosis (ALS), we generated transgenic mice with neuron-specific expression of a super-repressor form of the NF-&#x3ba;B inhibitor (I&#x3ba;B&#x3b1;-SR), which were then crossed with mice of both sexes, expressing ALS-linked gene mutants for TAR DNA-binding protein (TDP-43) and superoxide dismutase 1 (SOD1). Remarkably, neuronal expression of I&#x3ba;B&#x3b1;-SR transgene in mice expressing TDP-43<sup>A315T</sup> or TDP-43<sup>G348C</sup> mice led to a decrease in cytoplasmic to nuclear ratio of human TDP-43. The mitigation of TDP-43 neuropathology by I&#x3ba;B&#x3b1;-SR, which is likely due to an induction of autophagy, was associated with amelioration of cognitive and motor deficits as well as reduction of motor neuron loss and gliosis. Neuronal suppression of NF-&#x3ba;B activity in SOD1<sup>G93A</sup> mice also resulted in neuroprotection with reduction of misfolded SOD1 levels and significant extension of life span. The results suggest that neuronal NF-&#x3ba;B signaling constitutes a novel therapeutic target for ALS disease and related disorders with TDP-43 proteinopathy.<b>SIGNIFICANCE STATEMENT</b> This study reports that neuron-specific expression of I&#x3ba;B super-repressor mitigated behavioral and pathologic changes in transgenic mouse models of amyotrophic lateral sclerosis expressing mutant forms of either Tar DNA-binding protein 43 or superoxide dismutase. The results suggest that neuronal NF-&#x3ba;B signaling constitutes a novel therapeutic target for amyotrophic lateral sclerosis and related disorders with Tar DNA-binding protein 43 proteinopathy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Dutta et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dutta</LastName><ForeName>Kallol</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Qu&#xe9;bec City, Qu&#xe9;bec G1J 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thammisetty</LastName><ForeName>Sai Sampath</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Qu&#xe9;bec City, Qu&#xe9;bec G1J 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutej</LastName><ForeName>Hejer</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Qu&#xe9;bec City, Qu&#xe9;bec G1J 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bareil</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Qu&#xe9;bec City, Qu&#xe9;bec G1J 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Julien</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Qu&#xe9;bec City, Qu&#xe9;bec G1J 2G3, Canada jean-pierre.julien@fmed.ulaval.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neuroscience, Universit&#xe9; Laval, Qu&#xe9;bec City, Qu&#xe9;bec G1V 0A6, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>139874-52-5</RegistryNumber><NameOfSubstance UI="D000072000">NF-KappaB Inhibitor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurosci. 2021 Feb 10;41(6):1142-1144</RefSource><PMID Version="1">33568447</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072000" MajorTopicYN="N">NF-KappaB Inhibitor alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">I&#x3ba;B suppressor</Keyword><Keyword MajorTopicYN="N">NF-&#x3ba;B</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">superoxide dismutase</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32457070</ArticleId><ArticleId IdType="pmc">PMC7314413</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.0536-20.2020</ArticleId><ArticleId IdType="pii">JNEUROSCI.0536-20.2020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arqu&#xe9;s O, Chicote I, Tenbaum S, Puig I, Palmer H (2012) Standardized relative quantification of immunofluorescence tissue staining. Protocol Exchange. Advance online publication. Retrieved April 2, 2012. doi: 10.1038/protex.2012.008 10.1038/protex.2012.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/protex.2012.008</ArticleId><ArticleId IdType="doi">10.1038/protex.2012.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Zago P, D'Ambrogio A, Xu YF, Petrucelli L, Buratti E, Baralle FE (2008) Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci 121:3778&#x2013;3785. 10.1242/jcs.038950</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30:639&#x2013;649. 10.1523/JNEUROSCI.4988-09.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Be&#x10d;anovi&#x107; K, N&#xf8;rrem&#xf8;lle A, Neal SJ, Kay C, Collins JA, Arenillas D, Lilja T, Gaudenzi G, Manoharan S, Doty CN, Beck J, Lahiri N, Portales-Casamar E, Warby SC, Connolly C, De Souza RA, Tabrizi SJ, Hermanson O, Langbehn DR, Hayden MR, et al. (2015) A SNP in the HTT promoter alters NF-&#x3ba;B binding and is a bidirectional genetic modifier of Huntington disease. Nat Neurosci 18:807&#x2013;816. 10.1038/nn.4014</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4014</ArticleId><ArticleId IdType="pubmed">25938884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C, Chiang M, Toh EW, Chang CF, Huang T (2013) Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function. FEBS Lett 587:575&#x2013;582. 10.1016/j.febslet.2013.01.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2013.01.038</ArticleId><ArticleId IdType="pubmed">23384725</ArticleId></ArticleIdList></Reference><Reference><Citation>Conradi S, Ronnevi LO (1993) Selective vulnerability of alpha motor neurons in ALS: relation to autoantibodies toward acetylcholinesterase (AChE) in ALS patients. Brain Res Bull 30:369&#x2013;371. 10.1016/0361-9230(93)90267-f</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(93)90267-f</ArticleId><ArticleId IdType="pubmed">8457885</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosio C, Valle C, Casciati A, Iaccarino C, Carr&#xec; MT (2011) Astroglial inhibition of NF-&#x3ba;B does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS). PLoS One 6:e17187. 10.1371/journal.pone.0017187</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017187</ArticleId><ArticleId IdType="pmc">PMC3060799</ArticleId><ArticleId IdType="pubmed">21445241</ArticleId></ArticleIdList></Reference><Reference><Citation>Dion PA, Daoud H, Rouleau GA (2009) Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 10:769&#x2013;782. 10.1038/nrg2680</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2680</ArticleId><ArticleId IdType="pubmed">19823194</ArticleId></ArticleIdList></Reference><Reference><Citation>Djavaheri-Mergny M, Amelotti M, Mathieu J, Besan&#xe7;on F, Bauvy C, Souqu&#xe8;re S, Pierron G, Codogno P (2006) NF-&#x3ba;B activation represses tumor necrosis factor-&#x3b1;-induced autophagy. J Biol Chem 281:30373&#x2013;30382. 10.1074/jbc.M602097200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M602097200</ArticleId><ArticleId IdType="pubmed">16857678</ArticleId></ArticleIdList></Reference><Reference><Citation>Drachman DB, Rothstein JD (2000) Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 48:792&#x2013;795. 10.1002/1531-8249(200011)48:5&lt;792::AID-ANA14&gt;3.0.CO;2-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(200011)48:5&lt;792::AID-ANA14&gt;3.0.CO;2-5</ArticleId><ArticleId IdType="pubmed">11079544</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K, Patel P, Julien JP (2018) Protective effects of Withania somnifera extract in SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Exp Neurol 309:193&#x2013;204. 10.1016/j.expneurol.2018.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.08.008</ArticleId><ArticleId IdType="pubmed">30134145</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K, Patel P, Rahimian R, Phaneuf D, Julien JP (2017) Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Neurotherapeutics 14:447&#x2013;462. 10.1007/s13311-016-0499-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0499-2</ArticleId><ArticleId IdType="pmc">PMC5398980</ArticleId><ArticleId IdType="pubmed">27928708</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood PM, Qian L, Peterson LJ, Zhang F, Shi JS, Gao HM, Hong JS (2011) Transcriptional factor NF-&#x3ba;B as a target for therapy in Parkinson's disease. Parkinsons Dis 2011:216298. 10.4061/2011/216298</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/216298</ArticleId><ArticleId IdType="pmc">PMC3095232</ArticleId><ArticleId IdType="pubmed">21603248</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, Ladner KJ, Bevan AK, Foust KD, Godbout JP, Popovich PG, Guttridge DC, Kaspar BK (2014) Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron 81:1009&#x2013;1023. 10.1016/j.neuron.2014.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Friese A, Kaltschmidt JA, Ladle DR, Sigrist M, Jessell TM, Arber S (2009) Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc Natl Acad Sci USA 106:13588&#x2013;13593. 10.1073/pnas.0906809106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906809106</ArticleId><ArticleId IdType="pmc">PMC2716387</ArticleId><ArticleId IdType="pubmed">19651609</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H, Lin L, Haq IU, Zeng SM (2016) Inhibition of NF-kappaB promotes autophagy via JNK signaling pathway in porcine granulosa cells. Biochem Biophys Res Commun 473:311&#x2013;316. 10.1016/j.bbrc.2016.03.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.03.101</ArticleId><ArticleId IdType="pubmed">27016483</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier C, Devred F, Byrne D, Puppo R, Roman AY, Malesinski S, Golovin AV, Lebrun R, Ninkina NN, Tsvetkov PO (2017) Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates. Sci Rep 7:6812. 10.1038/s41598-017-07215-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07215-7</ArticleId><ArticleId IdType="pmc">PMC5533730</ArticleId><ArticleId IdType="pubmed">28754988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 [Suppl]:S81&#x2013;S96. 10.1016/s0092-8674(02)00703-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(02)00703-1</ArticleId><ArticleId IdType="pubmed">11983155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F, Soucy G, Larivi&#xe8;re R, Julien JP (2010) Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem 113:1188&#x2013;1199. 10.1111/j.1471-4159.2010.06683.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06683.x</ArticleId><ArticleId IdType="pubmed">20345765</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Shorter J (2017) Biology and pathobiology of TDP-43 and emergent therapeutic strategies. Cold Spring Harb Perspect Med 7:a024554 10.1101/cshperspect.a024554</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024554</ArticleId><ArticleId IdType="pmc">PMC5580514</ArticleId><ArticleId IdType="pubmed">27920024</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusel'nikova VV, Korzhevskiy DE (2015) NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Naturae 7:42&#x2013;47. 10.32607/20758251-2015-7-2-42-47</Citation><ArticleIdList><ArticleId IdType="doi">10.32607/20758251-2015-7-2-42-47</ArticleId><ArticleId IdType="pmc">PMC4463411</ArticleId><ArticleId IdType="pubmed">26085943</ArticleId></ArticleIdList></Reference><Reference><Citation>Harari OA, Liao JK (2010) NF-&#x3ba;B and innate immunity in ischemic stroke. Ann NY Acad Sci 1207:32&#x2013;40. 10.1111/j.1749-6632.2010.05735.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2010.05735.x</ArticleId><ArticleId IdType="pmc">PMC3807097</ArticleId><ArticleId IdType="pubmed">20955423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, de Assis DR, Vourc'h P, Andres CR, Corcia P, Lanznaster D, Blasco H (2019) The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain 142:1176&#x2013;1194. 10.1093/brain/awz078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SV, Kounatidis I (2017) Nuclear factor kappa B and Alzheimer disease, unifying genetic and environmental risk factors from cell to humans. Front Immunol 8:1805. 10.3389/fimmu.2017.01805</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01805</ArticleId><ArticleId IdType="pmc">PMC5732234</ArticleId><ArticleId IdType="pubmed">29312321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabe K, Kano O, Yanagihashi M, Ikeda K, Iwasaki Y (2014) Angiotensin- (1-7) inhibits NF-kappa B in glia cells of ALS model mice. J Neuroimmunol 275:118 10.1016/j.jneuroim.2014.08.314</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.08.314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke YD, van Hummel A, Stevens CH, Gladbach A, Ippati S, Bi M, Lee WS, Kruger S, van der Hoven J, Volkerling A, Bongers A, Halliday G, Haass NK, Kiernan M, Delerue F, Ittner LM (2015) Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol 130:661&#x2013;678. 10.1007/s00401-015-1486-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1486-0</ArticleId><ArticleId IdType="pubmed">26437864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutzberg GW. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312&#x2013;318. 10.1016/0166-2236(96)10049-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-2236(96)10049-7</ArticleId><ArticleId IdType="pubmed">8843599</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M, Sharma A, Lyashchenko AK, Shneider NA (2016) Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc Natl Acad Sci USA 113:E8316&#x2013;E8325. 10.1073/pnas.1605210113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Spencer NY, Pantazis NJ, Engelhardt JF (2011) Alsin and SOD1G93A regulate endosomal ROS production by glial cells and pro-inflammatory pathways responsible for neurotoxicity. J Biol Chem 286:40151&#x2013;40162. 10.1074/jbc.M111.279711</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.279711</ArticleId><ArticleId IdType="pmc">PMC3220533</ArticleId><ArticleId IdType="pubmed">21937428</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist IT, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SR, Hunter S, Jicha GA, Katsumata Y, Kawas CH, et al. (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus Working Group Report. Brain 142:1503&#x2013;1527. 10.1093/brain/awz186</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz186</ArticleId><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VY (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda Y, Imai S, Nakanishi I, Ichikawa T, Deguchi T (1995) Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol Int 45:933&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">8808298</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;gren SO, Stiedl O (2010) Passive avoidance. In: Encyclopedia of psychopharmacology (Stolerman IP, ed), pp 960&#x2013;967. Berlin: Springer.</Citation></Reference><Reference><Citation>Ohta Y, Tremblay C, Schneider JA, Bennett DA, Calon F, Julien JP (2014) Interaction of transactive response DNA binding protein 43 with nuclear factor &#x3ba;B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun 2:37&#x2013;37. 10.1186/2051-5960-2-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-37</ArticleId><ArticleId IdType="pmc">PMC4230634</ArticleId><ArticleId IdType="pubmed">24690380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N, Schurr C, Olde Heuvel F, Tang L, Li Q, Tasdogan A, Kimbara A, Nettekoven M, Ottaviani G, Raposo C, R&#xf6;ver S, Rogers&#x2010;Evans M, Rothenh&#xe4;usler B, Ullmer C, Fingerle J, Grether U, Knuesel I, Boeckers TM, Ludolph A, Wirth T, et al. (2018) NF&#x2010;&#x3ba;B activation in astrocytes drives a stage&#x2010;specific beneficial neuroimmunological response in ALS. EMBO J 37:e98697 10.15252/embj.201798697</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasetto L, Pozzi S, Castelnovo M, Basso M, Estevez AG, Fumagalli S, De Simoni MG, Castellaneta V, Bigini P, Restelli E, Chiesa R, Trojsi F, Monsurr&#xf2; MR, Callea L, Male&#x161;evi&#x107; M, Fischer G, Freschi M, Tortarolo M, Bendotti C, Bonetto V (2017) Targeting extracellular cyclophilin A reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis. J Neurosci 37:1413&#x2013;1427. 10.1523/JNEUROSCI.2462-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2462-16.2016</ArticleId><ArticleId IdType="pmc">PMC6705677</ArticleId><ArticleId IdType="pubmed">28011744</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V, Dutta K, Phaneuf D, Sobue G, Julien JP (2015) Ubiquilin-2 drives NF-&#x3ba;B activity and cytosolic TDP-43 aggregation in neuronal cells. Mol Brain 8:71. 10.1186/s13041-015-0162-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0162-6</ArticleId><ArticleId IdType="pmc">PMC4628361</ArticleId><ArticleId IdType="pubmed">26521126</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi S, Thammisetty SS, Codron P, Rahimian R, Plourde KV, Soucy G, Bareil C, Phaneuf D, Kriz J, Gravel C, Julien JP (2019) Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology. J Clin Invest 129:1581&#x2013;1595. 10.1172/JCI123931</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI123931</ArticleId><ArticleId IdType="pmc">PMC6436898</ArticleId><ArticleId IdType="pubmed">30667370</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako W, Ito H, Yoshida M, Koizumi H, Kamada M, Fujita K, Hashizume Y, Izumi Y, Kaji R (2012) Nuclear factor kappa B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. Clin Neuropathol 31:418&#x2013;423. 10.5414/NP300493</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300493</ArticleId><ArticleId IdType="pubmed">22762947</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino L, Bonafede R, Scambi I, Parrella E, Pizzi M, Mariotti R (2018) Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model. Sci Rep 8:12875. 10.1038/s41598-018-30659-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30659-4</ArticleId><ArticleId IdType="pmc">PMC6110772</ArticleId><ArticleId IdType="pubmed">30150770</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Chen HJ, Shaw CE (2015) TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12:352&#x2013;363. 10.1007/s13311-015-0338-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Vance C, Nishimura AL, Lee YB, Chen HJ, Urwin H, Sardone V, Mitchell JC, Rogelj B, Rubinsztein DC, Shaw CE (2014) Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci 127:1263&#x2013;1278. 10.1242/jcs.140087</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Shneider NA, Brown MN, Smith CA, Pickel J, Alvarez FJ (2009) Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev 4:42. 10.1186/1749-8104-4-42</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8104-4-42</ArticleId><ArticleId IdType="pmc">PMC2800842</ArticleId><ArticleId IdType="pubmed">19954518</ArticleId></ArticleIdList></Reference><Reference><Citation>Shodai A, Morimura T, Ido A, Uchida T, Ayaki T, Takahashi R, Kitazawa S, Suzuki S, Shirouzu M, Kigawa T, Muto Y, Yokoyama S, Takahashi R, Kitahara R, Ito H, Fujiwara N, Urushitani M (2013) Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem 288:14886&#x2013;14905. 10.1074/jbc.M113.451849</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.451849</ArticleId><ArticleId IdType="pmc">PMC3663511</ArticleId><ArticleId IdType="pubmed">23558684</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Elwood J, Greene WC (1996) Both amino- and carboxyl-terminal sequences within I kappa B alpha regulate its inducible degradation. Mol Cell Biol 16:1058&#x2013;1065. 10.1128/mcb.16.3.1058</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.16.3.1058</ArticleId><ArticleId IdType="pmc">PMC231088</ArticleId><ArticleId IdType="pubmed">8622650</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J, Julien JP (2011a) Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134:2610&#x2013;2626. 10.1093/brain/awr159</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr159</ArticleId><ArticleId IdType="pubmed">21752789</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J, Julien JP (2011b) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J Exp Med 208:2429&#x2013;2447. 10.1084/jem.20111313</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Uranishi H, Tetsuka T, Yamashita M, Asamitsu K, Shimizu M, Itoh M, Okamoto T (2001) Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J Biol Chem 276:13395&#x2013;13401. 10.1074/jbc.M011176200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M011176200</ArticleId><ArticleId IdType="pubmed">11278855</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9:108&#x2013;118. 10.1038/nn1603</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1603</ArticleId><ArticleId IdType="pubmed">16369483</ArticleId></ArticleIdList></Reference><Reference><Citation>Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43&#x2013;52. 10.1016/j.tibs.2004.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2004.11.009</ArticleId><ArticleId IdType="pubmed">15653325</ArticleId></ArticleIdList></Reference><Reference><Citation>Young K, Morrison H (2018) Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ. J Vis Exp 136:57648 10.3791/57648</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/57648</ArticleId><ArticleId IdType="pmc">PMC6103256</ArticleId><ArticleId IdType="pubmed">29939190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacco E, Martin SR, Thorogate R, Pastore A (2018) The RNA-recognition motifs of TAR DNA-binding protein 43 may play a role in the aberrant self-assembly of the protein. Front Mol Neurosci 11:372. 10.3389/fnmol.2018.00372</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00372</ArticleId><ArticleId IdType="pmc">PMC6190850</ArticleId><ArticleId IdType="pubmed">30356856</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>